Role of CD8+ lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

Journal of Virology

Volumn 75, Issue 21, 2001, Pages 10187-10199

  Lifson, J D ^a   Rossio, J L ^a   Piatak M , Jr ^a   Parks, T ^a   Li, L ^a   Kiser, R ^a   Coalter, V ^a   Fisher, B ^a   Flynn, B M ^a   Czajak, S ^a   Hirsch, V M ^a   Reimann, K A ^a   Schmitz, J E ^a   Ghrayeb, J ^a   Bischofberger, N ^a   Nowak, M A ^a   Desrosiers, R C ^a   Wodarz, D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD8 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; TENOFOVIR; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; INFECTION CONTROL; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SHORT COURSE THERAPY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VACCINATION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ADENINE; ANIMALS; ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; MACACA MULATTA; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRUS REPLICATION;

EID: 0034790979     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.21.10187-10199.2001     Document Type: Article

References (46)

1. The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1
2. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
3. Simian immunodeficiency virus: Production, inactivation, and characterization
4. CD56 identifies monocytes and not natural killer cells in rhesus macaques
5. HIV 1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
6. Strategies used by human immunodeficiency virus that allow persistent viral replication
7. Chemokine receptors and chemokines in HIV infection
8. Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells
9. + T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replication
10. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment and prevention
11. + T cell depletion in simian immunodeficiency virus-infected macaques
12. Protective immunity induced by live attenuated simian immunodeficiency virus
13. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: Inverse relation of degree of protection with level of attenuation
14. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
15. Containment of SIV infection: Cellular immune responses and protection from re-challenge following transient post-inoculation antiretroviral treatment
16. The extent of early viral replication is a critical determinant of the natural history of AIDS virus infection
17. Control of SIV rebound through structured treatment interruptions during early infection
18. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques
19. Memory CD8+ T cells in HIV infection
20. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus
21. Effects of in vivo CDS(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine
22. Suppression of acute viremia by short term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allow for the development of potent antiviral immune responses resulting in containment of infection
23. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection
24. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques
25. New concepts in the immunopathogenesis of HIV infection
26. Viral strategies of immune evasion
27. Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIV mne in protection against homologous cloned and uncloned virus challenge in macaques
28. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus
29. Immune control of HIV-1 after early treatment of acute infection
30. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques
31. Inactivation of HIV-1 infectivity with preservation of conformational and functional integrity of virion surface proteins
32. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
33. A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody
34. The replicative capacity of rhesus macaque peripheral blood mononuclear cells for simian immunodeficiency virus in vitro is predictive of the rate of progression to AIDS in vivo
35. + lymphocyte apoptosis in acutely S1V-infected rhesus macaques after short-term antiretroviral treatment
36. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection
37. Plasma SIV RNA viral load by real time quantification of product generation in RT PCR
38. In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV)
39. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl)adenine treatment for prevention of persistent simian immunodeficiency virus STVmne infection depends critically on timing of initiation and duration of treatment
40. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine
41. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival
42. A new theory of cytotoxic T-lymphocyte memory: Implications for HIV treatment
43. Transient post-inoculation antiretroviral treatment facilitates long term control of SIV infection, Philos
44. Protection by live attenuated simian immunodeficiency virus against heterologous challenge
45. Therapeutic vaccination against chronic viral infection: The importance of cooperation between CD4+ and CD8+ T cells